about
Beta Blocker for Chronic Wound HealingHemodynamic Study of Avanafil and Two α-Adrenergic Blockers,Doxazosin and TamsulosinAdrenergic Blockers for Cardiac Changes in Early Parkinson's DiseaseA Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma MedicationsDASH After TBI Study: Decreasing Adrenergic or Sympathetic Hyperactivity After Traumatic Brain InjuryCoreg and HSRs-Updated Analysis[11C]Yohimbine PET Study of alpha2-ARBeta2-adrenergic Agonism and Muscle RemodellingThe Effect of Ongoing Beta-blockers Administration on Analgesic Requirements in the Immediate Perioperative Period.High-flow Nasal Cannula Nebulization of Beta 2 Adrenergic Agonist During Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseHuman Beta-2 Adrenergic Stimulation and Muscle Glucose UptakeBeta-Blocker Evaluation in Survival Trial (BEST)CFTR Related Pancreatitis StudyInfluence of the Autonomic Nervous System in Response to Exercise in Hypertensive IndividualsLong-term Outcome After Gestational Diabetes and Diabetes in Pregnancy
P4844
Q179452-8746E2CB-BD41-4732-B093-BE6D73994F26Q191924-3288099F-C734-4B45-ACB3-E58B115BE520Q219626-3A9139BD-A5E0-4DE5-B98B-5F7B4A0BE774Q3704421-F47A18CF-B35C-41CD-B9E9-87828ECDA071Q418157-495B5E0C-4D63-4153-B4B2-DD0D704DC464Q420673-BFC0186C-2225-44C5-8349-4111324B4923Q5206163-37C5D4CA-29B8-4CCD-9E03-E3D384E64ECAQ7240579-BD8C972C-F036-4F48-AB95-92BFFD7F2945Q7706555-C3BD872D-D6DC-41AB-8D00-5C7757668F75Q780181-FFA08339-A001-471C-A9AD-48C4593E0107Q794152-4D10FEFA-B0A9-42A9-A54E-106E83D8319A
P2868
Q61933688-5DE8C3D4-75B1-4663-B85F-BA820C5EAFF2Q61936150-66184E1B-2C4B-465F-BE9F-CE54EFB067E5Q62030923-5199436F-952F-4D78-A69F-83DDC3CAF723Q63315663-765AD30C-AEE9-49E7-9BA8-DFF1E22942F4Q63336007-C335EED4-51F3-423A-AB19-9E2614E6EBC8Q63337910-5B4425C1-8795-4A2D-AE20-DA63CD42FCADQ63397507-FEC30B8B-3914-466A-A293-B0E9F2021756Q63398605-6ED2052C-1A94-443A-83C5-533A275F66A1Q63399755-D9A5B239-E393-42EA-9FDD-CF43BDAC517BQ63401042-85A03C9E-E0E1-41D7-A5F2-FEC9C77FA894Q63591650-6D78F4A9-D665-4B55-9FF9-44A962369EEDQ63811396-42BD3F88-7408-423C-AF6D-E97CE566A927Q86294016-DF191311-FD69-49A6-932A-7BFA3D06DE0BQ93214728-DF848537-A31E-46EB-8DCB-E05AD3042024Q96143502-E11A7EE9-981C-48FF-92C2-4774738844C6
P4844
description
drugs that act on adrenergic r ...... ease of adrenergic transmitter
@en
médicament qui agit sur les ré ...... relâchement des transmetteurs)
@fr
name
adrenergic agent
@en
adrenergt middel
@nn
agent adrénergique
@fr
type
label
adrenergic agent
@en
adrenergt middel
@nn
agent adrénergique
@fr
altLabel
adrenergic agents
@en
adrenergic drug
@en
adrenergic drugs
@en
adrenergics
@en
adrénergique
@fr
agents adrénergiques
@fr
médicament adrénergique
@fr
médicaments adrénergiques
@fr
prefLabel
adrenergic agent
@en
adrenergt middel
@nn
agent adrénergique
@fr
P486
P683
P486
P672
D27.505.519.625.050
D27.505.696.577.050